Stuart Essig

Overview

Gender
male

Stuart Essig is Chairman of the Board of Directors of Integra LifeSciences Holdings Corporation.

He has been Non-Executive Chairman since June 2012 and served as Executive Chairman from January 2012 until June 2012. He also served as Chief Executive Officer from December 1997 until January 2012, and President from December 1997 until November 2010. In addition, he has served as a director since he joined Integra in December 1997.

Before joining Integra, Stuart Essig supervised the medical technology practice at Goldman, Sachs & Co. as a Managing Director. Stuart Essig had ten years of broad health care experience at Goldman Sachs serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.

Stuart Essig has chaired Audit, Compensation and Nominating and Governance Committees and served on the boards of several NASDAQ and NYSE listed companies ranging in size from several hundred million dollars to more than $15 billion in market capitalization. Stuart Essig currently serves on the Board of Directors of St. Jude Medical Corporation and Chairman of the Board of Directors of Breg, Inc.

From March 2005 until August 2008, he served on the Board of Directors of Zimmer Holdings, Inc., and from 1998 to 2002 he served on the Board of Directors of Vital Signs, Inc. Stuart Essig has also served on the executive committee, nominating and governance committee and as treasurer of ADVAMED, the Advanced Medical Technology Association.

Stuart Essig is also involved in several non-profit charitable organizations, including from time to time having served on the boards of such organizations.

Jobs

Number of Current Jobs
2
Stuart Essig has 2 current jobs including Managing Partner at Prettybrook Partners , Chairman of the Board at Integra LifeSciences and .
Organization Name Title At Company Start Date End Date
Prettybrook Partners Managing Partner Oct 1, 2012 Detail
Integra LifeSciences Chairman of the Board Jan 1, 2012 Detail